{"count": 1, "results": [{"_id": "27219686", "pmid": 27219686, "title": "Diabetes and Cancer: a Review of Current Knowledge.", "journal": "Exp Clin Endocrinol Diabetes", "authors": ["Wojciechowska J", "Krajewski W", "Bolanowski M", "Kręcicki T", "Zatoński T"], "date": "2016-05-01T00:00:00Z", "doi": "10.1055/s-0042-100910", "meta_date_publication": "2016 May", "meta_volume": "124", "meta_issue": "5", "meta_pages": "263-75", "score": 50043.496, "text_hl": "The majority of studies concern @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, a drug of choice in @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@, and its anti-neoplastic and @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@-suppressing activity. ", "citations": {"NLM": "Wojciechowska J, Krajewski W, Bolanowski M, Kręcicki T, Zatoński T. Diabetes and Cancer: a Review of Current Knowledge. Exp Clin Endocrinol Diabetes. 2016 May;124(5):263-75. PMID: 27219686", "BibTeX": "@article{27219686, title={Diabetes and Cancer: a Review of Current Knowledge.}, author={Wojciechowska J and Krajewski W and Bolanowski M and Kręcicki T and Zatoński T}, journal={Exp Clin Endocrinol Diabetes}, volume={124}, number={5}, pages={263-75}}"}}]}